BIO is a curation and liquidity protocol for Decentralized Science (DeSci). Our mission is to accelerate biotechnology by giving global communities of patients, scientists and biotech professionals the ability to collectively fund, build and own tokenized biotech projects and intellectual property (IP).
The team behind BIO helped create Molecule, a tokenization platform for early-stage biomedicine, and VitaDAO, the largest decentralized community for longevity science. Building on these successes, BIO is designed to catalyze an onchain scientific economy through decentralized funding, incentives and liquidity.
The BIO token gives holders access to BIO's network of scientific communities and IP, enabling broad exposure to the DeSci economy.
Leveraging in-depth analyst evaluations, we have synthesized critical insights from expert assessments to deliver a robust outlook for BIO. Our analysts highlight strong fundamentals and favorable market sentiment, positioning BIO for significant upside potential in the near term. Based on this comprehensive expert analysis, we maintain a highly optimistic view of this stock. Our conclusion: BIO is a Strong Buy candidate.
BIO stock price ended at $0.047451 on 水曜日, after dropping 3.97%
On May 06, 2026 00:00, the price of BIO fell by 3.97%, dropping from $0.055323 to $0.047451 with 24h trading volume reaching $113.1M BIO.